We determined the frequencies of CD1c+ mDCs and CD304+ pDCs in both the blood and LN tissue of healthy controls (HCs), RA-risk individuals and early-RA patients by flow cytometry. The gene discussed is CD1C; the disease is rheumatoid arthritis.